Malirid 45mg (Primaquine)

Introduction

Malirid 45mg is a supplement to Primaquine, it is an antimalarial medicine that is primarily utilized to treat and prevent the treatment of malaria. It’s particularly efficient against the liver stages (hypnozoites) from Plasmodium Vivax as well as Plasmodium ovale and Plasmodium ovale, both of which are responsible for the return of malaria.

What is Primaquine?

Primaquine is an 8-aminoquinoline substance that stands out in antimalarial medications due to its ability to fight dormant liver manifestations (hypnozoites) that are malaria parasites. It is therefore essential to stop relapses and to find a complete cure for infection due to P. vivax as well as P. ovale.

Indications

Malirid 45 mg is recommended to treat:

• Radical cure of Plasmodium vivax and Plasmodium ovale malaria: To eliminate hypnozoites and avoid relapses.
• Malaria prophylaxis: In some settings, especially in those areas where P. vixax can be found, it is common.
• Terminal prophylaxis: In the aftermath of treatment for acute malaria, it is important to stop recrudescence.
• Gametocytocidal agent: To reduce the transmission of Plasmodium falciparum, the killing of gametocytes.

Mechanism of Action

Primarily, it acts within the liver and targets those forms that are dormant of parasites known as the hypnozoites. It blocks mitochondrial electron transportation and creates reactive oxygen compounds that harm parasites. This results in their demise. The precise mechanism of action isn’t yet fully understood, but it may involve an oxidative injury.

Dosage and Administration

• Radical Cure of Malaria:
  Most commonly, 15 mg base (equivalent roughly 26.3 mg of primaquine phosphate) every day over 14 consecutive days for adults.
  Tablets of Malirid 45 mg can be taken in the prescribed dose (consult specific local guidelines or the instructions of your physician).
• Malaria Prophylaxis:
  The dosage and time of treatment vary based on the area as well as risk, and the patient’s factors.
• Administration:
  Orally taken with food to lessen irritation of the gastrointestinal tract.
  Should only be taken under supervision by a physician, in particular due to the possibility of adverse side effects.

Pharmacokinetics

• Absorption: Very well absorbed verbally.
• Distribution: In the body, it is widely distributed.
• Metabolism: Hepatic metabolism involves active metabolites.
• Excretion: Most often, it is through the kidneys.
• Half-life: Between 4 and 7 hours.

Side Effects

Common Side Effects:

• Gastrointestinal upset: nausea, vomiting, abdominal pain.
• Headache.
• Dizziness.

Serious Side Effects:

• Hemolytic anemia: Particularly, in those suffering from G6PD deficiencies that can lead to dangerous, possibly life-threatening hemolysis.
• Methemoglobinemia: The condition occurs when hemoglobin has been changed, which can reduce oxygen supply.
• Rare allergic reactions: rash, itching, swelling.
• Leukopenia or agranulocytosis (rare).

Precautions and Contraindications

• G6PD Deficiency:
  The use of primaquine may cause serious hemolysis for those suffering from glucose-6-phosphate dehydrogenase deficiency. The testing of G6PD status before starting treatment is crucial.
• Pregnancy:
  Pregnancy is not recommended due to the potential for hemolysis within the fetus.
• Breastfeeding:
  Take care when using this product. Be cautious; Infant G6PD status not yet known.
• Patients who have anemia that is pre-existing or other hematologic conditions must be cautious when using this medication.

Drug Interactions

• Other drugs that cause methemoglobinemia or hemolysis must be avoided.
• Primaquine is known to interact with antimalarial drugs such as chloroquine. This combination is commonly used to provide an extreme cure.
• Tell your doctor about the medications you take.

Use in Special Populations

• Children: Making adjustments to your diet based on your body’s weight and age.
• Elderly: Making adjustments to your diet based upon the weight and age.
• Patients with renal or hepatic impairment: Be cautious; be sure to monitor carefully.

Monitoring

• Check for any signs of hemolysis, such as bloody urine, jaundice, tiredness, or pallor.
• Hemoglobin and blood count levels are measured during the treatment.
• Monitor for methemoglobinemia symptoms: cyanosis, shortness of breath.

Storage

• Keep at room temperature, free of light and moisture.
• Make sure that the area is safe for youngsters.

Patient Counseling

• Drink with meals to lessen stomach discomfort.
• Do the whole course, regardless of whether you feel more comfortable.
• Tell your physician if you have any history of G6PD deficiencies.
• Report any symptoms such as the appearance of dark urine, yellowing eyelids or skin, as well as unusual tiredness, immediately.
• Beware of alcohol while you are in treatment.
• Don’t take any other medication or supplementation without consulting your medical professional.

Summary

Malirid 45 mg (Primaquine) is an essential antimalarial medicine used for the treatment of radical disease and the treatment of relapses of P. vivax as well as P. ovale infection. Its unique action against liver hypnozoites helps prevent recurring malaria episodes. Due to the possibility of hemolytic anemia for those with G6PD deficiencies, screening before the treatment begins is crucial. In the right dosage under the supervision of a medical professional, Malirid is effective and generally safe.